{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:11:44Z","timestamp":1768252304461,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19) has substantially challenged healthcare systems worldwide. By investigating population characteristics and prescribing profiles, it is possible to generate hypotheses about the associations between specific drug-utilisation profiles and susceptibility to COVID-19 infection. A retrospective drug-utilisation study was carried out using routinely collected information from a healthcare database in Campania (Southern Italy). We aimed to discover the prevalence of drug utilisation (monotherapy and polytherapy) in COVID-19 versus non-COVID-19 patients in Campania (~\u20096 million inhabitants). The study cohort comprised 1532 individuals who tested positive for COVID-19. Drugs were grouped according to the Anatomical Therapeutic Chemical (ATC) classification system. We noted higher prevalence rates of the use of drugs in the ATC categories C01, B01 and M04, which was probably linked to related comorbidities (i.e., cardiovascular and metabolic). Nevertheless, the prevalence of the use of drugs acting on the renin-angiotensin system, such as antihypertensive drugs, was not higher in COVID-19 patients than in non-COVID-19 patients after adjustments for age and sex. These results highlight the need for further case\u2013control studies to define the effects of medications and comorbidities on susceptibility to and associated mortality from COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-021-88398-y","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T10:06:16Z","timestamp":1619431576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Drug-utilisation profiles and COVID-19"],"prefix":"10.1038","volume":"11","author":[{"given":"Valentina","family":"Orlando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Coscioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mucherino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Perrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Trama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Menditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"88398_CR1","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19), Situation Report\u201495. www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200424-sitrep-95-covid-19.pdf?sfvrsn=e8065831_4. Accessed on 4 April 2020."},{"issue":"1","key":"88398_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00404-4","volume":"10","author":"KS Yuen","year":"2020","unstructured":"Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P. & Jin, D. Y. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 10(1), 1\u20135 (2020).","journal-title":"Cell Biosci."},{"issue":"10227","key":"88398_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(20)30526-2","volume":"395","author":"C Wenham","year":"2020","unstructured":"Wenham, C., Smith, J. & Morgan, R. COVID-19: the gendered impacts of the outbreak. Lancet 395(10227), 846\u2013848 (2020).","journal-title":"Lancet"},{"key":"88398_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475\u2013481 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"88398_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li, B. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 109(5), 531\u2013538 (2020).","journal-title":"Clin. Res. Cardiol."},{"key":"88398_CR6","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S2213-2600(20)30153-3","volume":"8","author":"CJ Tignanelli","year":"2020","unstructured":"Tignanelli, C. J. et al. Antihypertensive drugs and risk of COVID-19?. Lancet Respir. Med. 8, e30\u2013e31 (2020).","journal-title":"Lancet Respir. Med."},{"key":"88398_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009249","author":"RT Gandhi","year":"2020","unstructured":"Gandhi, R. T., Lynch, J. B. & del Rio, C. Mild or moderate Covid-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMcp2009249 (2020).","journal-title":"N. Engl. J. Med."},{"key":"88398_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1017","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017 (2020).","journal-title":"JAMA Cardiol."},{"key":"88398_CR9","doi-asserted-by":"publisher","first-page":"e57278","DOI":"10.7554\/eLife.57278","volume":"9","author":"GP Rossi","year":"2020","unstructured":"Rossi, G. P., Sanga, V. & Barton, M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife 9, e57278 (2020).","journal-title":"Elife"},{"issue":"5","key":"88398_CR10","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South, A. M., Diz, D. & Chappell, M. C. COVID-19, ACE2 and the cardiovascular consequences. Am. J. Physiol. Heart Circ. Physiol. 318(5), H1084\u2013H1090 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"88398_CR11","doi-asserted-by":"publisher","first-page":"m1313","DOI":"10.1136\/bmj.m1313","volume":"369","author":"JK Aronson","year":"2020","unstructured":"Aronson, J. K. & Ferner, R. E. Drugs and the renin-angiotensin system in covid-19. BMJ 369, m1313 (2020).","journal-title":"BMJ"},{"issue":"7","key":"88398_CR12","doi-asserted-by":"publisher","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","volume":"9","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein, R., Kochen, M. M., Messerli, F. H. & Gr\u00e4ni, C. Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect?. J. Am. Heart Assoc. 9(7), e016509 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"88398_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fphar.2019.00870","volume":"10","author":"A Moreno-Juste","year":"2019","unstructured":"Moreno-Juste, A. et al. Treatment patterns of diabetes in Italy: a population-based study. Front. Pharmacol. 10, 870 (2019).","journal-title":"Front. Pharmacol."},{"key":"88398_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2147\/CEOR.S147558","volume":"9","author":"F Guerriero","year":"2017","unstructured":"Guerriero, F. et al. Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy. Clinicoecon. Outcomes Res. 9, 741 (2017).","journal-title":"Clinicoecon. Outcomes Res."},{"issue":"1","key":"88398_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12905-017-0424-9","volume":"17","author":"D Putignano","year":"2017","unstructured":"Putignano, D. et al. Differences in drug use between men and women: an Italian cross sectional study. BMC Women\u2019s Health 17(1), 73 (2017).","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"88398_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40520-013-0127-5","volume":"25","author":"G Iolascon","year":"2013","unstructured":"Iolascon, G. et al. Osteoporosis drugs in real-world clinical practice: an analysis of persistence. Aging Clin. Exp. Res. 25(1), 137\u2013141 (2013).","journal-title":"Aging Clin. Exp. Res."},{"issue":"2","key":"88398_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1573399811666150701120408","volume":"12","author":"V Orlando","year":"2016","unstructured":"Orlando, V. et al. Prescription patterns of antidiabetic treatment in the elderly. Results from Southern Italy. Curr. Diabetes Rev. 12(2), 100\u2013106 (2016).","journal-title":"Curr. Diabetes Rev."},{"key":"88398_CR18","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2147\/PPA.S164819","volume":"12","author":"E Menditto","year":"2018","unstructured":"Menditto, E. et al. Adherence to chronic medication in older populations: application of a common protocol among three European cohorts. Patient Prefer. Adherence 12, 1975 (2018).","journal-title":"Patient Prefer. Adherence"},{"issue":"5","key":"88398_CR19","first-page":"e138","volume":"20","author":"M Casula","year":"2014","unstructured":"Casula, M. et al. Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy. Am J Manag. Care 20(5), e138\u2013e145 (2014).","journal-title":"Am J Manag. Care"},{"key":"88398_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/RMHP.S223042","volume":"13","author":"V Orlando","year":"2020","unstructured":"Orlando, V. et al. Drug utilization pattern of antibiotics: the role of age, sex and municipalities in determining variation. Risk Manag. Healthc. Policy 13, 63 (2020).","journal-title":"Risk Manag. Healthc. Policy"},{"key":"88398_CR21","doi-asserted-by":"publisher","unstructured":"Italian Data Protection Authority. General authorisation to process personal data for scientific research purposes\u20141 March 2012 [1884019]. https:\/\/doi.org\/10.1094\/PDIS-11-11-0999-PDN.","DOI":"10.1094\/PDIS-11-11-0999-PDN"},{"key":"88398_CR22","unstructured":"Demo-Geodemo. Mappe, Popolazione, Statistiche Demografiche dell\u2019ISTAT. http:\/\/demo.istat.it\/. Accessed on 1 March 2020."},{"issue":"10229","key":"88398_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229), 1054\u20131062 (2020).","journal-title":"Lancet"},{"issue":"10223","key":"88398_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223), 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"88398_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102538","author":"Y Shoenfeld","year":"2020","unstructured":"Shoenfeld, Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun. Rev. https:\/\/doi.org\/10.1016\/j.autrev.2020.102538 (2020).","journal-title":"Autoimmun. Rev."},{"key":"88398_CR26","doi-asserted-by":"publisher","first-page":"138277","DOI":"10.1016\/j.scitotenv.2020.138277","volume":"725","author":"B Vellingiri","year":"2020","unstructured":"Vellingiri, B. et al. COVID-19: a promising cure for the global panic. Sci. Total Environ. 725, 138277 (2020).","journal-title":"Sci. Total Environ."},{"issue":"1","key":"88398_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-01588-5","volume":"7","author":"B Spaetgens","year":"2017","unstructured":"Spaetgens, B. et al. Risk of infections in patients with gout: a population-based cohort study. Sci. Rep. 7(1), 1\u20139 (2017).","journal-title":"Sci. Rep."},{"key":"88398_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1528-1167.2011.03035.x","volume":"52","author":"E Beghi","year":"2011","unstructured":"Beghi, E. & Shorvon, S. Antiepileptic drugs and the immune system. Epilepsia 52, 40\u201344 (2011).","journal-title":"Epilepsia"},{"key":"88398_CR29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923","author":"G Mancia","year":"2020","unstructured":"Mancia, G., Rea, F., Ludergnani, M., Apolone, G. & Corrao, G. Renin-angiotensin-aldosterone system blockers and the risk of covid-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2006923 (2020).","journal-title":"N. Engl. J. Med."},{"key":"88398_CR30","unstructured":"The European Society of Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic (2020). www.escardio.org\/static_file\/Escardio\/Education-General\/Topic%20pages\/Covid-19\/ESC%20Guidance%20Document\/ESC-Guidance-COVID-19-Pandemic.pdf. Accessed on 21 Apr 2020."},{"issue":"9","key":"88398_CR31","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta, N. et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5(9), 1020\u20131026. https:\/\/doi.org\/10.1001\/jamacardio.2020.1855 (2020).","journal-title":"JAMA Cardiol."},{"issue":"3","key":"88398_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","volume":"325","author":"RD Lopes","year":"2021","unstructured":"Lopes, R. D. et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA 325(3), 254\u2013264. https:\/\/doi.org\/10.1001\/jama.2020.25864 (2021).","journal-title":"JAMA"},{"key":"88398_CR33","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091 (2020).","journal-title":"BMJ"},{"issue":"4","key":"88398_CR34","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2213-2600(20)30117-X","volume":"8","author":"H Cai","year":"2020","unstructured":"Cai, H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir. Med. 8(4), e20 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"88398_CR35","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2589-7500(20)30026-1","volume":"2","author":"K Sun","year":"2020","unstructured":"Sun, K., Chen, J. & Viboud, C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digit. Health 2(4), e201\u2013e208 (2020).","journal-title":"Lancet Digit. Health"},{"key":"88398_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.08.20056861","author":"F Riccardo","year":"2020","unstructured":"Riccardo, F. et al. Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic. medRxiv https:\/\/doi.org\/10.1101\/2020.04.08.20056861 (2020).","journal-title":"medRxiv"},{"key":"88398_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4683","author":"G Onder","year":"2020","unstructured":"Onder, G., Rezza, G. & Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA https:\/\/doi.org\/10.1001\/jama.2020.4683 (2020).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88398-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88398-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:15:24Z","timestamp":1670051724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88398-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88398"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88398-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8913"}}